Annual Total Long Term Liabilities
$98.71 M
-$8.87 M-8.24%
December 31, 2023
Summary
- As of February 12, 2025, FATE annual total long term liabilities is $98.71 million, with the most recent change of -$8.87 million (-8.24%) on December 31, 2023.
- During the last 3 years, FATE annual total long term liabilities has fallen by -$53.74 million (-35.25%).
- FATE annual total long term liabilities is now -38.82% below its all-time high of $161.33 million, reached on December 31, 2021.
Performance
FATE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$95.22 M
-$1.82 M-1.88%
September 30, 2024
Summary
- As of February 12, 2025, FATE quarterly total long term liabilities is $95.22 million, with the most recent change of -$1.82 million (-1.88%) on September 30, 2024.
- Over the past year, FATE quarterly long term liabilities has dropped by -$4.46 million (-4.47%).
- FATE quarterly long term liabilities is now -41.35% below its all-time high of $162.35 million, reached on September 30, 2021.
Performance
FATE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FATE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.2% | -4.5% |
| 3 y3 years | -35.3% | -8.6% |
| 5 y5 years | +290.1% | +22.5% |
FATE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.8% | at low | -41.0% | at low |
| 5 y | 5-year | -38.8% | +232.2% | -41.4% | +220.5% |
| alltime | all time | -38.8% | >+9999.0% | -41.4% | >+9999.0% |
Fate Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $95.22 M(-1.9%) |
| Jun 2024 | - | $97.04 M(-1.4%) |
| Mar 2024 | - | $98.41 M(-0.3%) |
| Dec 2023 | $98.71 M(-8.2%) | $98.71 M(-1.0%) |
| Sep 2023 | - | $99.68 M(-2.6%) |
| Jun 2023 | - | $102.31 M(-1.8%) |
| Mar 2023 | - | $104.21 M(-3.1%) |
| Dec 2022 | $107.57 M(-33.3%) | $107.57 M(-15.6%) |
| Sep 2022 | - | $127.41 M(-5.7%) |
| Jun 2022 | - | $135.06 M(-8.2%) |
| Mar 2022 | - | $147.08 M(-8.8%) |
| Dec 2021 | $161.33 M(+5.8%) | $161.33 M(-0.6%) |
| Sep 2021 | - | $162.35 M(+2.8%) |
| Jun 2021 | - | $158.00 M(-2.0%) |
| Mar 2021 | - | $161.29 M(+5.8%) |
| Dec 2020 | $152.45 M(+413.1%) | $152.45 M(+3.1%) |
| Sep 2020 | - | $147.88 M(+10.2%) |
| Jun 2020 | - | $134.16 M(+72.6%) |
| Mar 2020 | - | $77.75 M(+161.7%) |
| Dec 2019 | $29.71 M(+17.4%) | $29.71 M(-5.9%) |
| Sep 2019 | - | $31.57 M(-26.5%) |
| Jun 2019 | - | $42.93 M(-6.4%) |
| Mar 2019 | - | $45.89 M(+81.4%) |
| Dec 2018 | $25.30 M | $25.30 M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $23.35 M(+55.1%) |
| Jun 2018 | - | $15.06 M(-4.9%) |
| Mar 2018 | - | $15.84 M(-7.1%) |
| Dec 2017 | $17.05 M(+154.3%) | $17.05 M(-0.9%) |
| Sep 2017 | - | $17.21 M(+61.0%) |
| Jun 2017 | - | $10.69 M(+133.6%) |
| Mar 2017 | - | $4.57 M(-31.8%) |
| Dec 2016 | $6.71 M(-59.3%) | $6.71 M(-27.4%) |
| Sep 2016 | - | $9.24 M(-21.1%) |
| Jun 2016 | - | $11.72 M(-16.8%) |
| Mar 2016 | - | $14.09 M(-14.5%) |
| Dec 2015 | $16.48 M(-9.8%) | $16.48 M(-12.4%) |
| Sep 2015 | - | $18.81 M(-10.8%) |
| Jun 2015 | - | $21.09 M(+25.4%) |
| Mar 2015 | - | $16.83 M(-7.9%) |
| Dec 2014 | $18.27 M(>+9900.0%) | $18.27 M(+91.9%) |
| Sep 2014 | - | $9.52 M(+9327.7%) |
| Jun 2014 | - | $101.00 K(-14.4%) |
| Mar 2014 | - | $118.00 K(-12.6%) |
| Dec 2013 | $135.00 K(-99.8%) | $135.00 K(-99.8%) |
| Sep 2013 | - | $79.95 M(+8823.1%) |
| Jun 2013 | - | $896.00 K(-98.5%) |
| Dec 2012 | $59.05 M(+7.6%) | $59.05 M |
| Dec 2011 | $54.86 M | - |
FAQ
- What is Fate Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Fate Therapeutics?
- What is Fate Therapeutics annual total long term liabilities year-on-year change?
- What is Fate Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Fate Therapeutics?
- What is Fate Therapeutics quarterly long term liabilities year-on-year change?
What is Fate Therapeutics annual total long term liabilities?
The current annual total long term liabilities of FATE is $98.71 M
What is the all time high annual total long term liabilities for Fate Therapeutics?
Fate Therapeutics all-time high annual total long term liabilities is $161.33 M
What is Fate Therapeutics annual total long term liabilities year-on-year change?
Over the past year, FATE annual total long term liabilities has changed by -$8.87 M (-8.24%)
What is Fate Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FATE is $95.22 M
What is the all time high quarterly long term liabilities for Fate Therapeutics?
Fate Therapeutics all-time high quarterly total long term liabilities is $162.35 M
What is Fate Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FATE quarterly total long term liabilities has changed by -$4.46 M (-4.47%)